Darren Malinoski, MD is the Chief Clinical Transformation Officer for the School of Medicine and a Professor of Surgery in the Division of Trauma at Oregon Health & Science University in Portland, Oregon.
Dr. Malinoski has been actively involved in numerous clinical, administrative, and academic activities related to organ donation, donor management, and recipient critical care for the past 12 years and considers these aspects of his career to be among the most rewarding.
A focal point for Dr. Malinoski’s research involves the incorporation of Donor Management Goals (DMGs) at the donor’s bedside. DMGs serve as critical care endpoints to help guide donor management. They also create a standardized framework for interventional research protocols. Dr. Malinoski is the physician leader of the UNOS DMG Workgroup, which launched the nation’s first web-based Registry that contains donor management and recipient outcome data elements in a single location that is accessible for both performance improvement projects and research purposes. Dr. Malinoski is also the Co-PI of the multi-OPO randomized controlled trial, “Mild Hypothermia and Machine Perfusion in Deceased Organ Donors for Protection against Delayed Graft Function in Kidney Transplant Recipients,” which utilized the DMG Web Portal as the foundation of its data and safety monitoring plan.
Dr. Malinoski has over 100 peer-reviewed publications and book chapters and is a member of several professional societies, including the American College of Surgeons, the American Association for the Surgery of Trauma, the Western Surgical Association, the Pacific Coast Surgical Association, and the American Society of Transplantation. He has served on the Advisory Boards, Executive Committees, and Leadership Councils of numerous Organ Donation and Transplant Organizations.
DMGs or Not? The Great Donor Management Debate
In this webinar, we will bring together a diverse group of experts from multiple OPOs to discuss the evolving landscape of DMGs. The session will feature insights from OPOs that utilize DMGs as well as those that do not, providing a well-rounded perspective on the advantages and challenges of both approaches. Participants will gain a deeper understanding of what DMGs are and how they impact organ preservation, donor outcomes, and overall efficiency. During our time, we will also cover alternative strategies used by OPOs that do not employ DMGs, offering insights into other effective methods of donor management.